Philips shares rose 12.6% after earnings, as investors rewarded a 70-basis-point adjusted EBITA margin increase to 13%, ahead of management’s expectations, alongside 8% order intake growth. The full-year outlook was reiterated; sales growth was more modest at approximately 3%, with Diagnosis & Treatment broadly flat and Connected Care orders down mid-single digit.
Philips shares gained modestly (+2.7%) following a quarter that largely met expectations, supported by steady order intake and margin expansion, though market reaction suggests investors were cautious on incremental upside.